Furthermore, NGAL levels may be elevated in other pathological conditions, such as hypertension, obesity, cardiovascular diseases, or metabolic complications such as insulin resistance, which limits the specificity of this marker [144]. This evidence concerns the gene LCN2 and hypertensive disorder.